TET2 loss has been shown to increase methylation at chemokine gene promoter regions in CRC [103], which alongside loss of nuclear TET2 localization correlates with a more aggressive metastatic phenotype [104]. The gene discussed is TET2; the disease is colorectal carcinoma.